Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Noha Rashad

6PUBLICATIONS

11CO-AUTHORS

Predictive and prognostic markersEnvironmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Models of care and place of birthEpidemiological modelling

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Oct 18, 2024

Early Onset Pancreatic Adenocarcinoma (EOPAC): presentation, clinical course and treatment outcomes in comparison to Average Onset Pancreatic Adenocarcinoma (AOPAC): a retrospective cohort study.

Noha Rashad, Abdelrahman Gouda, Esraa Sabra

|Mar 28, 2024

Early-Onset Colorectal Cancer in Egypt: Pathological Characters, Patterns of Care, and Survival Compared to Average-Age Onset Colorectal Cancer: A Retrospective Multicenter Study.

Noha Rashad, Salem Eid Salem, Mohamed A M Meheissen

|Mar 07, 2022

Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020.

Noha Rashad, Mohamed Abdulla, Mohamed Farouk

|Feb 04, 2020

Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt.

Gihan Hamdy Elsisi, Yousery Nada, Noha Rashad

|Nov 28, 2018

Cost-effectiveness of sorafenib versus best supportive care in advanced hepatocellular carcinoma in Egypt.

Gihan Hamdy Elsisi, Yousery Nada, Noha Rashad

|Nov 11, 2017

Outcomes of treatment with sorafenib in Egyptian patients with hepatocellular carcinoma: a retrospective cohort study.

Yousery Nada, Noha Rashad, Mai Eissa

Pageof 1

Frequent Collaborators

2 joint publications

Salem Eid Salem

1 joint publications

Omar Abdel-Rahman

1 joint publications

Gihan Hamdy Elsisi

1 joint publications

Khaled Kamal

1 joint publications

Mohamed Abdelkhalek

1 joint publications

Loay Kassem

1 joint publications

Emad Shash

1 joint publications

Nashwa Kordy

1 joint publications

Hazem El Mansy

1 joint publications

Mohyeldin Saber Abdelhalim

Frequent Collaborators

2 joint publications

Salem Eid Salem

1 joint publications

Omar Abdel-Rahman

1 joint publications

Gihan Hamdy Elsisi

1 joint publications

Khaled Kamal

Top Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on : Feb 12, 2022

See more related videos

Top Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on : Feb 12, 2022

See more related videos